Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Medium Risk
Moderate dilution risk
Last updated: June 12, 2026
Risk Assessment Details
Potential Dilution:
4040.4% of current shares
Recent Dilution:
0% (2 years)
Historical Dilution Factor:
minimal recent dilution
Outstanding Shares
11M
Potential Supply
440M
Additional shares possible
Splits
None
Past 2 years
Summary
HKPD currently has 11M outstanding shares. with significant dilution risk as 444M authorized shares could dilute existing holders by 4040.4%. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.
Share Structure Timeline
Outstanding Shares
Total Supply
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Jun 12, 2026 |
F-3 filing: Cellyan Biotechnology Co., Ltd. has filed an F-3 shelf registration statement to offer up to $200,000,000 of common stock, debt securities, warrants, rights, and units from time to time. |
11M | 440M |
| Aug 14, 2025 |
20-F filing | 11.0M shares outstanding |
11M | 0 |